Tuesday, May 23, 2023 9:43:41 AM
There is also a somewhat new face book chat in the F-book group many are positive there, a few good people there also : ) lately not much talk in any of the groups lol because of course just waiting on the data as u know.
ps. holding of course but ignoring the Negative u know whats lol.....
I think Bucillamine could help with something like but we will see.
Ah Yea Covid is far from over ....
ps. holding of course but ignoring the Negative u know whats lol.....
I think Bucillamine could help with something like but we will see.
📌Post-COVID-19 symptoms can linger for 2 years and are associated with prolonged inflammation.
— Outbreak Updates (@outbreakupdates) May 23, 2023
Patients with prolonged inflammation showed elevated terminally differentiated memory T cells in their blood; 54% had symptoms at 12 months. https://t.co/v02bnYT5xf
Ah Yea Covid is far from over ....
China’s New Covid Wave Set to See 65 Million Cases a Week ⚠️ https://t.co/4PVEi0SPI1
— Jess (@MeetJess) May 22, 2023
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
